FB
Forlong Biotechnology
Clinical-stage biotech company developing transformative cytokine therapies.
About
Forlong Biotechnology is a clinical-stage biotechnology company focused on developing transformative cytokine therapies for patients with severe unmet medical needs. The company recently completed a Series Pre-B financing round of RMB 120 million (approximately USD 17.5 million).
Technology stack
detected 2026-06-14Est. monthly stack spend~$70/mo
Emailnone
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Forlong Biotechnology do?
Forlong Biotechnology is a clinical-stage biotechnology company focused on developing transformative cytokine therapies for patients with severe unmet medical needs. The company recently completed a Series Pre-B financing round of RMB 120 million (approximately USD 17.5 million).
How much funding has Forlong Biotechnology raised?
Forlong Biotechnology has raised a total of $23M in funding. The most recent round on record is Series Pre-B.
Where is Forlong Biotechnology headquartered?
Forlong Biotechnology is headquartered in Shanghai, China.
What industry does Forlong Biotechnology operate in?
Forlong Biotechnology operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.